Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection

Virology Journal

Volumn 1, Issue , 2004, Pages

  Cook, W James ^a,b   Kramer, Martha F ^c   Walker, Russell M ^a   Burwell, Timothy J ^a   Holman, Holly A ^c   Coen, Donald M ^c   Knipe, David M ^c  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b GlycoFi Incorporated   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; RNA; TOLL LIKE RECEPTOR; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSCRIPTION; HERPES SIMPLEX; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; LATENT PERIOD; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VIRUS PATHOGENESIS;

ANIMALS; CHEMOKINES; CORNEA; GANGLIA; GENE EXPRESSION REGULATION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; LEUKOCYTES; MICE; MICE, INBRED ICR; RECEPTORS, CHEMOKINE; RNA, MESSENGER; VIRUS LATENCY;

EID: 15744365499     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-1-5     Document Type: Article

References (36)

1. Whitton LJ, Oldstone MBA: The immune response to viruses. Fields Virology, 4th ed Edited by: Knipe D M and Howley P M. Philadelphia, PA, Lippincott, Williams and Wilkins; 2001:285-320.
2. Leib DA, Coen DM, Bogard CL, Hicks KA, Yager DR, Knipe DM, Tyler KL, Schaffer PA: Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 1989, 63:759-768.
3. Chen S-H, Garber DA, Schaffer PA, Knipe DM, Coen DM: Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of viral replication and reactivation. Virology 2000, 278:207-216.
4. Kramer MF, Chen SH, Knipe DM, Coen DM: Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J Virol 1998, 72:1177-1185.
5. Kramer MF, Coen DM: Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol 1995, 69:1389-1399.
6. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT: RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 1987, 235:1056-1059.
7. Liu T, Khanna KM, Chen XP, Fink DJ, Hendricks RL: CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. Journal of Experimental Medicine 2000, 191:1459-1466.
8. Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL: Herpes simplex virus-specific memory CD8(+) T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 2003, 18:593-603.
9. Cantin EM, Hinton DR, Chen J, Opehshaw H: Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 1995, 69:4898-4905.
10. Halford WP, Gebhardt BM, Carr DJJ: Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 1996, 157:3542-3549.
11. Shimeld C, Whiteland JL, Williams NA, Easty DL, Hill TJ: Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. Journal of General Virology 1997, 78:3317-3325.
12. Morrison LA, Knipe DM: Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology 1996, 220:402-413.
13. Murphy CG, Lucas WT, Means R, Czajak S, Hale CL, Lifson JD, Kauer A, Johnson RP, Knipe DM, Desrosiers RC: Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol 2000, 74:7745-7753.
14. Sozzani S, Allavena P, Vecchi A, Mantovani A: The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 1999, 66:1-9.
15. von Andrian UH, MacKay CR: T-cell function and migration. N Engl J Med 2000, 343:1020-1034.
16. Thomas J, Kanangat S, Rouse BT: Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. Journal of Interferon & Cytokine Research 1998, 18:681-690.
17. Tumpey TM, Cheng H, Yan XT, Oakes JE, Lausch RN: Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J Leukoc Biol 1998, 63:486-492.
18. Kanangat S, Babu JS, Knipe DM, Rouse BT: HSV-1 mediated modulation of cytokine gene expression in a permissive cell line: Selective up-regulation of IL6 gene expression. Virology 1996, 219:295-300.
19. Melchjorsen J, Pedersen FS, Mogensen SC, Paludan SR: Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0. J Virol 2002, 76:2780-2788.
20. Kurt-Jones E, Mandell L, Cerny A, Chan M, Zhou S, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Neonatal herpes simplex infection: Herpes simplex virus 1 interaction with TLR2 contributes to lethal encephalitis. PNAS 2004, 101:1315-1320.
21. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003, 198:513-520.
22. Hempel DM, Smith KA, Claussen KA, Perricone MA: Analysis of cellular immune responses in the peripheral blood of mice using real-time RT-PCR. J Immun Methods 2002, 259:129-138.
23. Overbergh L, Valckx D, Waer M, Mathieu C: Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999, 11:305-312.
24. Wen SF, Xie L, McDonald M, Digiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen L: Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Cancer Gene Therapy 2000, 7:1469-1480.
25. Chen S-H, Lee LY, Garber DA, Schaffer PA, Knipe DM, Coen DM: Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J Virol 2002, 76:4764-4772.
26. Babu JS, Thomas J, Kanangat D, Morrison LA, Knipe DM, Rouse BT: Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 1996, 70:101-107.
27. Kramer MF, Cook WJ, Roth FR, Zhu J, Holman H, Knipe DM, Coen DM: Latent herpes virus infection of sensory neurons alters neuronal gene expression. J Virol 2003, 77:9533-9541.
28. Weinberg JB, Lutzke ML, Efstathiou S, Kunkel SL, Rochford R: Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol 2002, 76:10518-10523.
29. Luster AD: The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002, 14:129-135.
30. Whitley RJ: Herpes Simplex Viruses. Fields Virology, 4th ed Edited by: Knipe D M and Howley P M. Philadelphia, PA, Lippincott, Williams and Wilkins; 2001:2461-2509.
31. Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, Psaty BM, Tracy RP, Kuller LH, Kronmal RA: Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : The Cardiovascular Health Study. Circulation 2000, 102:2335-2340.
32. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone M. A. Jr, Luster AD, Luscinskas FW, Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718-723.
33. Wald A, Link K: Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002, 185:45-52.
34. Brockman M, Knipe DM: Herpes simplex virus vectors elicit a durable antibody response in mice despite the presence of preexisting host immunity. J Virol 2002, 76:3678-3687.
35. Hocknell PK, Wiley RD, Wang X, Evans TG, Bowers WJ, Hanke T, Federoff HJ, Dewhurst S: Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses. J Virol 2002, 76:5565-5580.
36. Coen DM, Fleming H.E.,Jr., Leslie LK, Retondo MJ: Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. J Virol 1985, 53:477-488.